Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (OtherCHJTF) and Moderna (MRNA)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on CSPC Pharmaceutical Group (CHJTF – Research Report) and Moderna (MRNA – Research Report).
Confident Investing Starts Here:
CSPC Pharmaceutical Group (CHJTF)
Jefferies analyst Chu Wang downgraded CSPC Pharmaceutical Group to Sell yesterday and set a price target of HK$5.00. The company's shares closed last Tuesday at $0.81.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CSPC Pharmaceutical Group with a $0.84 average price target.
Moderna (MRNA)
In a report issued on May 31, Courtney Breen from Bernstein maintained a Hold rating on Moderna. The company's shares closed last Friday at $26.56.
According to TipRanks.com, Breen is a 2-star analyst with an average return of -0.1% and a 27.8% success rate. Breen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Gilead Sciences.
Moderna has an analyst consensus of Hold, with a price target consensus of $49.36, implying an 87.4% upside from current levels. In a report issued on May 27, Barclays also maintained a Hold rating on the stock with a $40.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
3 Global Penny Stocks With Market Caps Over US$400M To Watch
Global markets have been navigating a complex landscape, with U.S. stocks closing higher amid ongoing trade policy discussions and easing inflation rates. In this context, investors are increasingly looking for opportunities that balance affordability with potential growth. Penny stocks, though often seen as a relic of the past, continue to offer intriguing prospects; these typically smaller or newer companies can provide significant upside when backed by strong financials. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.525 A$71.7M ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Foresight Group Holdings (LSE:FSG) £4.02 £452.42M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.70 SEK277.44M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Tasmea (ASX:TEA) A$3.06 A$732.54M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ LSL Property Services (LSE:LSL) £2.81 £290.33M ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.38 HK$50.26B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,595 stocks from our Global Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★★ Overview: STI Education Systems Holdings, Inc., with a market cap of ₱14.24 billion, operates through its subsidiaries to offer a variety of educational services in the Philippines. Operations: The company generates revenue of ₱5.49 billion from its educational services, including schools, colleges, and universities in the Philippines. Market Cap: ₱14.24B STI Education Systems Holdings, Inc. demonstrates a stable financial position with revenue of ₱5.49 billion and net income growth to ₱1,600.84 million for the recent nine months. The company's earnings have grown by 49.2% over the past year, surpassing industry averages, although this is below its five-year average growth rate of 62.7%. Its net debt to equity ratio of 0.7% is satisfactory, and short-term assets exceed liabilities significantly. Despite a low return on equity at 17.7%, STI offers high-quality earnings and reliable dividends at 2.68%, trading well below estimated fair value with experienced management in place. Click to explore a detailed breakdown of our findings in STI Education Systems Holdings' financial health report. Gain insights into STI Education Systems Holdings' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinopec Shanghai Petrochemical Company Limited, along with its subsidiaries, engages in the manufacturing and sale of petroleum and chemical products in China, with a market capitalization of approximately HK$26.49 billion. Operations: No specific revenue segments are reported for the company. Market Cap: HK$26.49B Sinopec Shanghai Petrochemical Company Limited has shown resilience despite challenges, with recent strategic moves like the Steam Sales Contract with Baling New Materials potentially enhancing resource utilization and reducing costs. The company has become profitable in the past year, although its return on equity remains low at 0.6%. While earnings have declined over five years, they are forecast to grow significantly. The company's financial stability is supported by short-term assets exceeding liabilities and a strong cash position relative to debt, bolstered by a substantial share buyback program that reflects confidence in its valuation and future prospects. Dive into the specifics of Sinopec Shanghai Petrochemical here with our thorough balance sheet health report. Learn about Sinopec Shanghai Petrochemical's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Infund Holding Co., Ltd. operates in China, focusing on the production of micro enameled wire and veterinary vaccines, with a market cap of CN¥3.47 billion. Operations: Infund Holding Co., Ltd. has not reported any specific revenue segments. Market Cap: CN¥3.47B Infund Holding Co., Ltd. has shown significant revenue growth, reporting CN¥294.68 million for Q1 2025 compared to CN¥16.65 million a year ago, transitioning from a net loss to a net income of CN¥14.21 million. Despite being unprofitable in the past, the company has reduced its losses over five years by 26.2% annually and improved its debt-to-equity ratio from 11.3% to 1.9%. Short-term assets exceed liabilities, providing some financial stability; however, with less than a year of cash runway and negative return on equity (-12.88%), financial challenges persist amidst stable weekly volatility (8%). Click here and access our complete financial health analysis report to understand the dynamics of Infund Holding. Understand Infund Holding's track record by examining our performance history report. Investigate our full lineup of 5,595 Global Penny Stocks right here. Seeking Other Investments? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 24 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include PSE:STI SEHK:338 and SZSE:002141. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Business Insider
7 hours ago
- Business Insider
DBS Sticks to Their Buy Rating for Q Technology (Group) Co (1478)
DBS analyst Jim Hin Kwong Au maintained a Buy rating on Q Technology (Group) Co (1478 – Research Report) today. The company's shares opened today at HK$6.59. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Hin Kwong Au covers the Technology sector, focusing on stocks such as BYD Electronic (International) Co, Apple, and Sunny Optical Technology (Group) Co. According to TipRanks, Hin Kwong Au has an average return of 8.7% and a 52.59% success rate on recommended stocks. Currently, the analyst consensus on Q Technology (Group) Co is a Moderate Buy with an average price target of HK$9.25. The company has a one-year high of HK$9.26 and a one-year low of HK$3.37. Currently, Q Technology (Group) Co has an average volume of 6.6M.
Yahoo
13 hours ago
- Yahoo
Three Promising Asian Stocks with Strong Potential
As global markets navigate the complexities of trade policies and economic indicators, Asian markets present unique opportunities for investors seeking growth in a dynamic environment. With smaller-cap indexes showing resilience despite broader market fluctuations, identifying stocks with strong fundamentals and growth potential becomes crucial. Name Debt To Equity Revenue Growth Earnings Growth Health Rating Wuxi Double Elephant Micro Fibre MaterialLtd 6.32% 9.86% 52.64% ★★★★★★ Hangzhou Fortune Gas Cryogenic Group 0.01% 22.78% 17.11% ★★★★★★ Kyoritsu Electric 6.30% 4.83% 15.38% ★★★★★★ Advanced International Multitech 35.32% 3.62% 1.11% ★★★★★★ Shangri-La Hotel NA 23.33% 39.56% ★★★★★★ Miwon Chemicals 0.12% 10.40% 16.52% ★★★★★★ Otec 7.14% 4.39% 6.95% ★★★★★☆ Kangping Technology (Suzhou) 23.90% 1.60% 16.23% ★★★★★☆ Jinlihua Electric 48.71% 7.36% 31.30% ★★★★★☆ Guangdong Tloong Technology GroupLtd 39.59% -7.11% -21.90% ★★★★☆☆ Click here to see the full list of 2607 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. Let's dive into some prime choices out of from the screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: BaTeLab Co., Ltd. focuses on the research, development, and sale of analog integrated circuit patterned wafers for packaging and testing solutions in China, with a market capitalization of HK$4.04 billion. Operations: BaTeLab generates revenue primarily from the sale of analog IC patterned wafers and electronic components, amounting to CN¥578.81 million. The company's financial performance is influenced by its ability to manage costs associated with research, development, and production within this segment. BaTeLab, a nimble player in the semiconductor space, has outpaced its industry with a remarkable 52.6% earnings growth over the past year. Despite not being free cash flow positive, it trades at an attractive value compared to peers and boasts more cash than total debt. Recent moves include a follow-on equity offering of HKD 120 million and changes in company bylaws, signaling strategic shifts. The share price has been volatile lately; however, earnings are forecasted to grow by 25.5% annually, suggesting potential for future expansion amidst industry challenges. Get an in-depth perspective on BaTeLab's performance by reading our health report here. Assess BaTeLab's past performance with our detailed historical performance reports. Simply Wall St Value Rating: ★★★★★★ Overview: Beijing Highlander Digital Technology Co., Ltd. operates in the technology sector with a focus on digital solutions and has a market capitalization of CN¥13.44 billion. Operations: The company generates revenue primarily from its digital technology solutions. It has a market capitalization of CN¥13.44 billion. Beijing Highlander Digital Technology has shown a remarkable turnaround, transitioning from a net loss of CNY 116.36 million last year to a net income of CNY 8.21 million for the full year ending December 2024. This improvement is reflected in their basic earnings per share, which shifted from a loss of CNY 0.1609 to an earnings figure of CNY 0.0114 per share. The first quarter of 2025 continued this positive trend with sales reaching CNY 346.45 million compared to just CNY 46.88 million in the same period last year, illustrating significant revenue growth and operational efficiency gains within this small but promising entity in Asia's tech landscape. Navigate through the intricacies of Beijing Highlander Digital Technology with our comprehensive health report here. Explore historical data to track Beijing Highlander Digital Technology's performance over time in our Past section. Simply Wall St Value Rating: ★★★★★★ Overview: Test Research, Inc. operates in the design, assembly, manufacture, sale, and maintenance of automated inspection and testing equipment across Asia, the United States, Europe, and other international markets with a market cap of NT$31.06 billion. Operations: Test Research generates revenue primarily from the design, assembly, manufacture, sale, and maintenance of automated testing equipment, amounting to NT$6.79 billion. The company's financial performance is marked by a focus on these core activities across its international markets. Test Research, a nimble player in the electronics sector, reported impressive earnings growth of 65.3% over the past year, outpacing the industry average of 14.2%. With no debt on its books for five years and a price-to-earnings ratio of 15.9x, it offers good value compared to the broader Taiwan market at 18.3x. The company recently announced a cash dividend payout totaling TWD 1,181 million (TWD 5 per share), reflecting strong financial health and profitability. Despite recent share price volatility, Test Research's high-quality earnings and free cash flow positivity signal robust operational performance. Click here to discover the nuances of Test Research with our detailed analytical health report. Learn about Test Research's historical performance. Unlock more gems! Our Asian Undiscovered Gems With Strong Fundamentals screener has unearthed 2604 more companies for you to here to unveil our expertly curated list of 2607 Asian Undiscovered Gems With Strong Fundamentals. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2149 SZSE:300065 and TWSE:3030. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
